Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals’ product portfolio with sterile ...

This agreement represents a strategic step in innovation for Centrient. It will catalyse the expansion and diversification of their product portfolio while driving the development of sustainable and ...

Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial ...

RIJSWIJK, Netherlands and BOSTON, May 25, 2023 /PRNewswire/ -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and ...

Centrient Pharmaceuticals, the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals has completed the acquisition of Astral SteriTech. With the ...

ROTTERDAM, The Netherlands, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Centrient Pharmaceuticals, the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins ...

Centrient Pharmaceuticals, a global leader in statins, and antifungals, has announced the expansion of its Corporate Social Responsibility (CSR) initiatives. Underway across global operations, these ...

Further strengthens Centrient Pharmaceuticals' position as the global business-to-business industry leader in beta-lactam antibiotics Broadens Centrient Pharmaceuticals' product portfolio with sterile ...

RIJSWIJK, Netherlands & BARCELONA, Spain--(BUSINESS WIRE)--Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, today announced an agreement with Centrient ...

Rotterdam, the Netherlands, February 15th, 2021, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in ...